SEC Info - CASI Pharmaceuticals Holdings, Inc.

SEC Info℠

Home

Help

Please Sign In

CASI Pharmaceuticals Holdings, Inc. – ‘EFFECT’ on 2/14/23

On: Tuesday, 2/14/23, at 12:15am ET · As of: 2/13/23 · Effective: 2/13/23 · Accession #: 9999999995-23-406 · File #: 333-269479

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/13/23  CASI Pharmas Holdings, Inc.       EFFECT      2/13/23    1:2K                                     SEC #5

SEC Notice of Effectiveness

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: EFFECT      SEC Notice of Effectiveness -- primary_doc.xml/1.1  HTML      3K

This ‘EFFECT’ Document is an XML Data File that may be rendered in various formats:

Effectiveness Notice – Plain Text – SEC Website – EDGAR System – XML Data – <?xml?> File

SEC Info℠ rendering: SEC Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 13, 2023 4:00 P.M.

Form:

F-4

CIK:	1962738
Company Name:	CASI Pharmaceuticals Holdings, Inc.
File Number:	333-269479

↑Top

Filing Submission 9999999995-23-000406 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

CASI Pharmaceuticals Holdings, Inc. – ‘EFFECT’ on 2/14/23

On: Tuesday, 2/14/23, at 12:15am ET · As of: 2/13/23 · Effective: 2/13/23 · Accession #: 9999999995-23-406 · File #: 333-269479

SEC Notice of EffectivenessFiling Table of Contents

This ‘EFFECT’ Document is an XML Data File that may be rendered in various formats:

SEC Notice of Effectiveness

Filing Table of Contents